Nephrocare Health Services Ltd (NEPHROPLUS) Stock Price & News

NEPHROPLUS:NSE

Nephrocare Health Services Ltd

₹611.00

-1.00%

(-6.15) 1D

Oct 15, 3:30:00 PM GMT+5:30 · INR

All symbols

	Symbol	Price	Change	% Change

Last report

Aug 12, 2026

Fiscal period

Q1 2027

₹3.11 / ₹3.55

-12.39%miss

Revenue / Est. (INR)

2.82B / 2.70B

+4.31%beat

Fiscal Q1 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in INR

Loading Previous Earnings...

All values in INR	Jun 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.28B	2.60B	2.66B	2.82B
Cost of goods sold	1.37B	1.52B	1.85B	1.62B
Cost of revenue	1.37B	1.52B	1.85B	1.62B
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-	-	251.70M	-
Operating expense	624.58M	684.30M	503.40M	799.44M
Total operating expenses	2.00B	2.21B	2.35B	2.42B
Operating income	280.47M	390.04M	304.70M	393.43M
Other non operating income	65.76M	33.16M	-119.95M	74.59M
EBT including unusual items	285.19M	363.60M	332.19M	410.30M
EBT excluding unusual items	285.19M	363.60M	266.31M	410.30M
Income tax expense	48.15M	41.20M	28.49M	90.56M
Effective tax rate	16.88%	11.33%	8.58%	22.07%
Other operating expenses	429.38M	465.69M	5.03M	554.04M
Net income	237.04M	322.40M	303.70M	319.74M
Net profit margin	10.41%	12.41%	11.43%	11.35%
Earnings per share	-	-	-	3.11
Interest and investment income	-	-	97.07M	-
Interest expense	-61.04M	-59.60M	-9.04M	-22.06M
Net interest expenses	-61.04M	-59.60M	88.03M	-22.06M
Depreciation and amortization charges	195.20M	218.61M	246.63M	245.40M
EBITDA	432.64M	542.22M	492.71M	581.44M
Gain or loss from assets sale	-	-	-	-

Finance